STRS Ohio’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

STRS Ohio’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-83,100	Closed	-$554K	–	2044
2023 Q3	$554K	Buy	83,100 +12,100	+17%	+$101K	﹤0.01%	1201
2023 Q2	$643K	Buy	+71,000	New	+$626K	﹤0.01%	1130
2023 Q1	–	Sell	-17,200	Closed	-$125K	–	2088
2022 Q4	$125K	Hold	17,200	–	–	﹤0.01%	1692
2022 Q3	$132K	Hold	17,200	–	–	﹤0.01%	1706
2022 Q2	$117K	Buy	+17,200	New	+$132K	﹤0.01%	1736

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

STRS Ohio's PNT Position: Q4 2023 in Review

STRS Ohio sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 83,100 shares — an estimated $554K sold.

STRS Ohio first reported a position in PNT in Q2 2022 and held it in 5 quarters. The position peaked at $643K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

STRS Ohio reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
STRS Ohio sold 83,100 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $554K.
STRS Ohio first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 5 quarters.
STRS Ohio's POINT Biopharma Global Inc. Common Stock position peaked at $643K in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on STRS Ohio's 13F filing for Q4 2023, filed 30 Jan 2024.